Abstract
Cross-sectional qualitative study mapping AI adoption across Southeast Asian health systems, covering policy landscapes, implementation challenges, and collaboration networks. Examines how ASEAN health systems are navigating the transition to AI-enabled care delivery.
About This Research
Publisher: JMIR Year: 2025 Type: Case Study
Source: Insights Into AI Adoption Within Health Systems in Southeast Asia
Relevance
Industries: Government, Telecommunications Pillars: AI Readiness & Strategy Regions: Southeast Asia
Diagnostic Imaging as Entry Point
Diagnostic imaging analysis represents the most prevalent and advanced AI application category across surveyed health systems, driven by the convergence of standardized image data formats, quantifiable performance benchmarks, and acute radiologist shortages throughout the region. AI-assisted screening for conditions including diabetic retinopathy, tuberculosis, and breast cancer demonstrates particular traction in settings where specialist availability cannot meet screening demand volume. The research documents deployment models ranging from cloud-based interpretation services accessible via mobile devices to embedded software integrated within existing picture archiving systems.
Data Ecosystem Fragmentation
Southeast Asian health systems exhibit extreme data ecosystem fragmentation arising from heterogeneous electronic health record systems, inconsistent coding standards, incomplete digitization of paper-based records, and limited interoperability between public and private sector health information systems. This fragmentation constrains AI model development by limiting access to the comprehensive longitudinal patient data necessary for training accurate predictive algorithms. The study evaluates emerging health information exchange initiatives in Singapore and Thailand that aim to create integrated data environments while preserving patient privacy through federated analytics architectures.
Regulatory and Ethical Infrastructure
Health AI governance in Southeast Asia remains predominantly guided by general medical device regulation frameworks not specifically designed for algorithmic decision support tools. The research identifies regulatory gaps including absence of specific approval pathways for continuously learning AI systems, unclear liability frameworks for AI-assisted clinical decisions, and insufficient post-market surveillance mechanisms for monitoring deployed algorithm performance. Recommendations include establishing dedicated health AI regulatory units within existing health technology assessment agencies and developing regional harmonization guidelines that reduce duplicative evaluation burdens for systems targeting multi-country deployment.